NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?
External Expert Profile
Ruth Puig-Peiro
Latest Publications
The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe
Payment Models for Multi-Indication Therapies
Read more
© Photology1971/Shutterstock
The Value of Vaccines in Maintaining Health System Capacity in England
How is Quality of Life Measured for Health Technology Assessments?
Realising The Broader Value of Vaccines in the UK: Ready for Prime Time?
Read more
© Mitrovix
